Secretion of acute-phase proteins before and after hepatocellular carcinoma resection

Journal of the Formosan Medical Association

Volumn 98, Issue 2, 1999, Pages 85-91

  Hu, Rey Heng ^a   Lee, Po Huang ^a   Yu, Sen Chang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute phase reactant; C reactive protein; Hepatectomy; Hepatocellular carcinoma; Hepatocyte growth factor; Interleukin 6

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; HEPATITIS B SURFACE ANTIGEN; INDOCYANINE GREEN; INTERLEUKIN 6; SCATTER FACTOR;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER TEST; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MALE; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; TREATMENT OUTCOME; TUMOR VOLUME;

ACUTE-PHASE PROTEINS; ADULT; AGED; C-REACTIVE PROTEIN; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-6; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0033035787     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pullicino EA, Carli F, Poole S, et al: The relationship between the circulating concentrations of interleukin-6, tumor necrosis factor and acute phase response to elective surgery and accidental injury. Lymphokine Res 1990;9: 231-8.
2. Shiota G, Kawasaki H, Nakamura T, et al: Characterization of double transgenic mice expressing hepatocyte growth factor and transforming growth factor alpha. Res Commun Mol Pathol Pharmacol 1995;90:17-24.
3. Ishiki Y, Ohnishi H, Muto Y, et al: Direct evidence that hepatocyte growth factor is a hepatotropic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992;16:1227-35.
4. Webber EM, Godowski PJ, Faausto N: In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994;19:489-97.
5. Shiota G, Wang CT, Nakamura T, et al: Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 1994;19:962-72.
6. Shiota G, Okano J, Kawasaki H, et al: Serum hepatocyte growth factor levels in liver disease: clinical implications. Hepatology 1995;21:106-12.
7. Hioki O, Watanabe A, Minemura M, et al: Clinical significance of serum hepatocyte growth factor levels in liver disease. J Med 1993;24:35-46.
8. Noji S, Tashiro K, Koyama E, et al: Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990;173:42-7.
9. Schirmacher P, Geerts A, Pietangelo A, et al: Hepatocyte growth factor/hepatotropin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992;15:5-11.
10. D'Errico A, Fiorentino M, Ponzetto A, et al: Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does. Hepatology 1996;24:60-4.
11. Hamazaki K, Tagashira H, Mimura T, et al: Changes in IL-6 and IL-8 after hepatectomy in patients with liver cirrhosis. Hepatogastroenterology 1995;42:13-7.
12. Malaguarnera M, Di Fazio I, Laurino A, et al: Role of interleukin-6 in hepatocellular carcinoma. Bull Cancer (Paris) 1996;83:379-84.
13. Zhang D, Sun M, Samols D, et al: STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem 1996;271:9503-9.
14. Wolf HK, Zarnegar R, Michalopulos GK: Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 1991;14: 488-94.
15. Yoshinaga Y, Matsuno Y, Fugita S, et al: Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 1993;84:1150-8.
16. Wang Y, Selden AC, Morgan N, et al: Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 1994;144:675-82.
17. Hu RH, Lee PH, Yu SC, Sheu JC, Lai MY: Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma. Hepatogastroenterology. (In press)
18. Selden C, Farnaud S, Ding SF, et al: Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver tumors. J Hepatol 1994;21:227-34.
19. von Schweinitz D, Hadam MR, Welte K, et al: Production of interleukin-1 beta and interleukin-6 in hepatoblastoma. Int J Cancer 1993;53:728-34.
20. Nakazaki H: Preoperative and postoperative cytokines in patients with cancer. Cancer 1992;70:709-13.
21. Matsuda Y, Kawata S, Nagase T, et al: Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor. Cancer 1994;73:53-7.
22. Ikei S, Ogawa M, Beppu T, et al: Changes in IL-6, IL-8, C-reactive protein and pancreatic secretory trypsin inhibitor after transcatheter arterial chemo-embolization therapy for hepatocellular carcinoma. Cytokine 1992;4:581-4.
23. Yamazaki H, Nishimoto N, Oi H, et al: Serum interleukin-6 as a predictor of the therapeutic effect and adverse reactions after transcatheter arterial embolization. Cytokine 1995;7:191-5.
24. Fabris C, Pirisi M, Soardo G, et al: Diagnostic usefulness of acute-phase protein measurement in hepatocellular carcinoma. Cancer Invest 1996;14:103-8.
25. Yamazaki H, Oi H, Matsushita M, et al: C-reactive protein as an indicator of effect and adverse reaction to transcatheter arterial embolization. Radiat Med 1995; 13:163-5.